Recent Advances in Nanozyme‐Based Materials for Inflammatory Bowel Disease

Abstract

AbstractInflammatory bowel disease (IBD) is a type of chronic inflammatory disorder that interferes with the patient's lifestyle and, in extreme situations, can be deadly. Fortunately, with the ever‐deepening understanding of the pathological cause of IBD, recent studies using nanozyme‐based materials have indicated the potential toward effective IBD treatment. In this review, the recent advancement of nanozymes for the treatment of enteritis is summarized from the perspectives of the structural design of nanozyme‐based materials and therapeutic strategies, intending to serve as a reference to produce effective nanozymes for moderating inflammation in the future. Last but not least, the potential and current restrictions for using nanozymes in IBD will also be discussed. In short, this review may provide a guidance for the development of innovative enzyme‐mimetic nanomaterials that offer a novel and efficient approach toward the effective treatment of IBD.